Recent Research | Page 74 | Aplastic Anemia and MDS International Foundation

Recent Research

Compiled for your convenience are the latest articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology. Articles are obtained from the National Library of Medicine’s MEDLINE database and date back to 2010.

Article Title Original Publication Datesort descending Journal Bone Marrow Disease
Prognostic relevance of lymphocytopenia, monocytopenia and lymphocyte-to-monocyte ratio in primary myelodysplastic syndromes: a single center experience in 889 patients Mar 2017 Blood Cancer J myelodysplastic syndromes (MDS)
An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes Mar 2017 Am J Hematol myelodysplastic syndromes (MDS)
Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes Apr 2017 J Clin Oncol myelodysplastic syndromes (MDS)
Cellular immune profiling after sequential clofarabine and lenalidomide for high risk myelodysplastic syndromes and acute myeloid leukemia Apr 2017 Leuk Res Rep
Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia Apr 2017 N Engl J Med aplastic anemia
Updates on the pathophysiology and treatment of aplastic anemia: a comprehensive review. Apr 2017 Expert Rev Hematol aplastic anemia
Population pharmacokinetics of fludarabine in patients with aplastic anemia and Fanconi anemia undergoing allogeneic hematopoietic stem cell transplantation. May 2017 Bone Marrow Transplant aplastic anemia
Patterns of treatment and costs associated with transfusion burden in patients with myelodysplastic syndromes. May 2017 Leuk Lymphoma myelodysplastic syndromes (MDS)
Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117 May 2017 J Clin Oncol myelodysplastic syndromes (MDS)
Mutated ASXL1 and number of somatic mutations as possible indicators of progression to chronic myelomonocytic leukemia of myelodysplastic syndromes with single or multilineage dysplasia May 2017 Haematologica myelodysplastic syndromes (MDS)